99 related articles for article (PubMed ID: 3415269)
1. [A study of CDDP in the treatment of patients with gastric and esophageal cancers, with special reference to the evaluation of renal functions before and after CDDP administration].
Sasaki E; Namatame K; Hirose C; Hamai N; Onomura Y; Miyata N; Kusumoto S; Makuuchi M; Iwai H; Asakawa K
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2713-7. PubMed ID: 3415269
[TBL] [Abstract][Full Text] [Related]
2. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
[TBL] [Abstract][Full Text] [Related]
3. [Effects of fractionated low dose Cisplatin on renal functions of patients with gastric carcinoma].
Li Y; Shen L; Li J; Jin ML
Ai Zheng; 2007 Dec; 26(12):1354-6. PubMed ID: 18076800
[TBL] [Abstract][Full Text] [Related]
4. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
Ujiie T; Maruta H; Ito N
Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical modulation of 5-FU--effect of low dose CDDP].
Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
[TBL] [Abstract][Full Text] [Related]
7. [Changes in renal function on response to rapid administration of cisplatinum].
Mikata N; Suzuki M; Takeuchi T; Kunisawa Y; Fukutani K; Kawabe K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):508-13. PubMed ID: 3954374
[TBL] [Abstract][Full Text] [Related]
8. [A case of synchronous esophageal and gastric cancer successfully treated by combination TS-1/CDDP therapy with irradiation].
Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H; Harada S
Gan To Kagaku Ryoho; 2004 Feb; 31(2):251-4. PubMed ID: 14997762
[TBL] [Abstract][Full Text] [Related]
9. [Transition of renal function after repeated intraperitoneal CDDP administration].
Arai K; Kitamura M; Iwasaki Y
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1476-8. PubMed ID: 8854784
[TBL] [Abstract][Full Text] [Related]
10. [Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
Nishimura G; Horiuchi C; Yoshida T; Kawakami M; Yabuki K; Taguchi T; Nagao J; Kondo N; Masuda Y; Matsuda H; Mikami Y; Tsukuda M
Gan To Kagaku Ryoho; 2006 Apr; 33(4):463-6. PubMed ID: 16612154
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with 5-FU modulated by low-dose CDDP for advanced cancers and recurrent cases of metastasis].
Shinkai K; Kida H; Hisano H; Shibasaki S; Yano H; Nomura M
Gan To Kagaku Ryoho; 1999 Feb; 26(3):329-32. PubMed ID: 10065096
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
13. [Complete response in a case of simultaneous esophageal and gastric cancer treated by combined radiotherapy and chemotherapy of TS-1 and CDDP].
Iwase H; Kaida S; Nakamura M; Mizuno T; Iyo T; Nakarai K; Indo T; Hiraiwa A
Gan To Kagaku Ryoho; 2002 Mar; 29(3):455-9. PubMed ID: 11915739
[TBL] [Abstract][Full Text] [Related]
14. [Preventive effect of prostaglandin E1 on cisplatin-induced nephrotoxicity].
Takayama K; Nakanishi Y; Takano K; Harada T; Inoue K; Osaki S; Minami T; Hara N
Gan To Kagaku Ryoho; 1999 Mar; 26(4):503-8. PubMed ID: 10097747
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
Yogi S; Ikeuchi T; Kai Y
Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
[TBL] [Abstract][Full Text] [Related]
16. [Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction].
Hirosawa A; Sakai S; Iizuka K; Niitani H; Hayashibara K; Tsuboi E
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2870-5. PubMed ID: 3662543
[TBL] [Abstract][Full Text] [Related]
17. [Acute change in urinary NAG activity following CDDP administration].
Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
Hinyokika Kiyo; 1986 Mar; 32(3):369-73. PubMed ID: 3728241
[TBL] [Abstract][Full Text] [Related]
18. [The effect of bismuth subnitrate on cisplatin toxicity].
Chen JT; Kurokawa Y; Nakayama K; Saito K; Sakamoto K; Fukuda K; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):815-22. PubMed ID: 3298471
[TBL] [Abstract][Full Text] [Related]
19. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
Nakata B; Hirakawa K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
[TBL] [Abstract][Full Text] [Related]
20. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]